RHJA
ALBO
Rice Hall James & Associates’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-513,525
| Closed | -$11.1M | – | 274 |
|
|
2022
Q4 | $11.1M | Buy |
513,525
+9,387
| +2% | +$203K | 0.64% | 46 |
|
|
2022
Q3 | $9.76M | Buy |
504,138
+38,334
| +8% | +$742K | 0.57% | 48 |
|
|
2022
Q2 | $9.25M | Sell |
465,804
-9,187
| -2% | -$182K | 0.45% | 59 |
|
|
2022
Q1 | $14.2M | Buy |
474,991
+16,980
| +4% | +$507K | 0.56% | 53 |
|
|
2021
Q4 | $10.7M | Sell |
458,011
-49,670
| -10% | -$1.16M | 0.38% | 65 |
|
|
2021
Q3 | $15.8M | Sell |
507,681
-2,786
| -0.5% | -$86.9K | 0.59% | 53 |
|
|
2021
Q2 | $18M | Sell |
510,467
-62,432
| -11% | -$2.2M | 0.64% | 52 |
|
|
2021
Q1 | $20.2M | Buy |
572,899
+315,527
| +123% | +$11.1M | 0.66% | 47 |
|
|
2020
Q4 | $9.65M | Buy |
257,372
+170,014
| +195% | +$6.38M | 0.34% | 64 |
|
|
2020
Q3 | $2.92M | Buy |
+87,358
| New | +$2.92M | 0.12% | 130 |
|